These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10913752)

  • 1. Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporter.
    Lepist EI; Kusk T; Larsen DH; Andersen D; Frokjaer S; Taub ME; Veski P; Lennernäs H; Friedrichsen G; Steffansen B
    Eur J Pharm Sci; 2000 Jul; 11(1):43-50. PubMed ID: 10913752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability, metabolism and transport of D-Asp(OBzl)-Ala--a model prodrug with affinity for the oligopeptide transporter.
    Steffansen B; Lepist EI; Taub ME; Larsen BD; Frokjaer S; Lennernäs H
    Eur J Pharm Sci; 1999 Apr; 8(1):67-73. PubMed ID: 10072480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model prodrugs for the intestinal oligopeptide transporter: model drug release in aqueous solution and in various biological media.
    Nielsen CU; Andersen R; Brodin B; Frokjaer S; Steffansen B
    J Control Release; 2001 May; 73(1):21-30. PubMed ID: 11337056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism.
    Thomsen AE; Friedrichsen GM; Sørensen AH; Andersen R; Nielsen CU; Brodin B; Begtrup M; Frokjaer S; Steffansen B
    J Control Release; 2003 Jan; 86(2-3):279-92. PubMed ID: 12526824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
    Nielsen CU; Andersen R; Brodin B; Frokjaer S; Taub ME; Steffansen B
    J Control Release; 2001 Sep; 76(1-2):129-38. PubMed ID: 11532319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model prodrugs designed for the intestinal peptide transporter. A synthetic approach for coupling of hydroxy-containing compounds to dipeptides.
    Friedrichsen GM; Nielsen CU; Steffansen B; Begtrup M
    Eur J Pharm Sci; 2001 Aug; 14(1):13-9. PubMed ID: 11457645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of enzymatically stable dipeptides for enhancement of intestinal permeability. Synthesis and in vitro evaluation of dipeptide-coupled compounds.
    Friedrichsen GM; Jakobsen P; Taub M; Begtrup M
    Bioorg Med Chem; 2001 Oct; 9(10):2625-32. PubMed ID: 11557350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrimidine and nucleoside gamma-esters of L-Glu-Sar: synthesis, stability and interaction with hPEPT1.
    Eriksson AH; Elm PL; Begtrup M; Brodin B; Nielsen R; Steffansen B
    Eur J Pharm Sci; 2005 May; 25(1):145-54. PubMed ID: 15854810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
    Han HK; Oh DM; Amidon GL
    Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
    Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
    ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
    Anand BS; Patel J; Mitra AK
    J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.
    Sala-Rabanal M; Loo DD; Hirayama BA; Turk E; Wright EM
    J Physiol; 2006 Jul; 574(Pt 1):149-66. PubMed ID: 16627568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs.
    Omkvist DH; Trangbæk DJ; Mildon J; Paine JS; Brodin B; Begtrup M; Nielsen CU
    Eur J Pharm Biopharm; 2011 Feb; 77(2):327-31. PubMed ID: 21147219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hPEPT1 affinity and translocation of selected Gln-Sar and Glu-Sar dipeptide derivatives.
    Eriksson AH; Elm PL; Begtrup M; Nielsen R; Steffansen B; Brodin B
    Mol Pharm; 2005; 2(3):242-9. PubMed ID: 15934785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina.
    Kansara V; Hao Y; Mitra AK
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):321-34. PubMed ID: 17803430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations.
    Våbenø J; Nielsen CU; Ingebrigtsen T; Lejon T; Steffansen B; Luthman K
    J Med Chem; 2004 Sep; 47(19):4755-65. PubMed ID: 15341490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir.
    Talluri RS; Samanta SK; Gaudana R; Mitra AK
    Int J Pharm; 2008 Sep; 361(1-2):118-24. PubMed ID: 18573320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2.
    Sala-Rabanal M; Loo DD; Hirayama BA; Wright EM
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1422-32. PubMed ID: 18367661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.